Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Discovery of a potent, selective and in vivo active mGluR4 positive allosteric modulator

Hopkins CR, Niswender CM, Lewis LM, Weaver CD, Lindsley CW.

2009 Dec 18 [updated 2010 Oct 20]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.

[Treatment and pathogenesis of Parkinson's disease]

Mochizuki H.

Rinsho Shinkeigaku. 2010 Sep;50(9):623-7. doi: 10.5692/clinicalneurol.50.623.

Long-term safety of single and multiple infrared transcranial laser treatments in Sprague-Dawley rats

McCarthy TJ, De Taboada L, Hildebrandt PK, Ziemer EL, Richieri SP, Streeter J.

Photomed Laser Surg. 2010 Oct;28(5):663-7. doi: 10.1089/pho.2009.2581.

α-Synuclein and dopamine at the crossroads of Parkinson's disease

Venda LL, Cragg SJ, Buchman VL, Wade-Martins R.

Trends Neurosci. 2010 Dec;33(12):559-68. doi: 10.1016/j.tins.2010.09.004. Epub 2010 Oct 18.

Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study

Goetz CG, Ouyang B, Negron A, Stebbins GT.

Neurology. 2010 Nov 16;75(20):1773-9. doi: 10.1212/WNL.0b013e3181fd6158. Epub 2010 Oct 20.

CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias

Ballard CG, Jones EL.

Neurology. 2010 Nov 16;75(20):1760-1. doi: 10.1212/WNL.0b013e3181fd6393. Epub 2010 Oct 20.

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease

Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, Ishigami N, Tamaoka A, Nakagawa M, El-Agnaf OM.

Neurology. 2010 Nov 16;75(20):1766-72. doi: 10.1212/WNL.0b013e3181fd613b. Epub 2010 Oct 20.

[The feasibility of synthetic enhancer substances for preventive nanotherapy]

Miklya I.

Neuropsychopharmacol Hung. 2010 Sep;12(3):395-403.

Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions

Mollenhauer B, Förstl H, Deuschl G, Storch A, Oertel W, Trenkwalder C.

Dtsch Arztebl Int. 2010 Oct;107(39):684-91. doi: 10.3238/arztebl.2010.0684. Epub 2010 Oct 1.

Laxatives as a risk factor for iatrogenic falls in elderly subjects: myth or reality?

Bloch F, Thibaud M, Dugué B, Brèque C, Rigaud AS, Kemoun G.

Drugs Aging. 2010 Nov 1;27(11):895-901. doi: 10.2165/11584280-000000000-00000.

[Pharmacological Parkinsonism vs. dementia with Lewy bodies]

Peña Llamas E, Fernández García C, Fernández Blázquez MA.

Neurologia. 2010 Sep;25(7):459-61.

Placebo effects in neurological diseases

Dumitriu A, Popescu BO.

J Med Life. 2010 Apr-Jun;3(2):114-21.

Cutting the Gordian knot: the blockage of the jejunal tube, a rare complication of Duodopa infusion treatment

Negreanu LM, Popescu BO, Babiuc RD, Ene A, Andronescu D, Băjenaru OA.

J Med Life. 2010 Apr-Jun;3(2):191-2.

Loneliness and the rate of motor decline in old age: the Rush Memory and Aging Project, a community-based cohort study

Buchman AS, Boyle PA, Wilson RS, James BD, Leurgans SE, Arnold SE, Bennett DA.

BMC Geriatr. 2010 Oct 22;10:77. doi: 10.1186/1471-2318-10-77.

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW.

Lancet Neurol. 2010 Dec;9(12):1164-1172. doi: 10.1016/S1474-4422(10)70254-4. Epub 2010 Oct 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias